DELINEATE-Prospective

Recruiting Observational Study
Valve Disease, Aortic Mitral Regurgitation (MR) Aortic Stenosis Valvular Heart Disease Tricuspid Regurgitation (TR) Aortic Regurgitation
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Columbia University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Heart disease is the leading cause of death in the United States, and echocardiography (or "echo") is the most common way doctors look at the heart. Echo is safe, painless, and can detect major heart problems, including weak heart pumping and valve disease. Valve disease, especially aortic stenosis (narrowing) and mitral regurgitation (leakage), is common in older adults but often goes undiagnose…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Attending cardiologist employed by Columbia University, ColumbiaDoctors, or NewYork Presbyterian Hospital who reads transthoracic echocardiograms in the Columbia echocardiography laboratory * Provided informed consent to take part in the questionnaires or pivotal study Exclus…
Contacts

Heidi S Hartman, MD

212-305-3068

hl2738@cumc.columbia.edu

CONTACT

Michelle Castillo, BS

212-305-9161

mc5067@cumc.columbia.edu

CONTACT